AFFECT: a prospective, open-label, multicenter trial to evaluate the feasibility and safety of a short-term treatment with subcutaneous certoparin in patients with persistent non-valvular atrial fibrillation

✍ Scribed by Ulrich Tebbe; Ralph Oeckinghaus; Karl-Friedrich Appel; Hubertus Heuer; Hendrik Haake; Egbert Eggers; Karlheinz Seidel; Jan Adams; Job Harenberg

• Publisher: Springer
• Year: 2008
• Tongue: English
• Weight: 267 KB
• Volume: 97
• Category: Article
• ISSN: 1861-0684
• DOI: 10.1007/s00392-008-0644-y